A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...

Kirsty Treen, 39, is now in remission following surgery and chemotherapy at Royal United Hospitals Bath NHS Foundation Trust, ...

A standard diagnostic test for ovarian cancer is less effective in detecting the disease among Black and Native American ...

She believed that had she had a CA125 blood test earlier - CA125 is a protein in the blood and can be raised in women with ...

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are on the ...

Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, ...

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is ...

A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on ...

Corcept Therapeutics said on Monday its experimental drug in combination with chemotherapy helped delay progression of a type ...

Polymer-coated nanoparticles loaded with therapeutic drugs show significant promise for cancer treatment, including ovarian ...

Corcept Therapeutics said on Monday its experimental combination ovarian cancer drug improved survival in patients with a ...